The Current Ratio as of December 2024 (TTM) for Plus Therapeutics, Inc. (PSTV) is 0.44

According to Plus Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.44. This represents a change of -21.76% compared to the average of 0.57 of the last 4 quarters.

Plus Therapeutics, Inc. (PSTV) Historical Current Ratio (quarterly & annually)

How has PSTV Current Ratio performed in the past?

The mean historical Current Ratio of Plus Therapeutics, Inc. over the last ten years is 1.53. The current 0.44 Current Ratio has changed 2.80% with respect to the historical average. Over the past ten years (40 quarters), PSTV's Current Ratio was at its highest in in the March 2022 quarter at 4.49. The Current Ratio was at its lowest in in the June 2019 quarter at 0.38.

Plus Therapeutics, Inc. (PSTV) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Plus Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Plus Therapeutics, Inc. (PSTV) Average Current Ratio

How has PSTV Current Ratio performed in the past?

The current Current Ratio of Plus Therapeutics, Inc. (PSTV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Plus Therapeutics, Inc. (PSTV) Current Ratio vs. Peers

How is PSTV’s Current Ratio compared to its peers?

Plus Therapeutics, Inc.’s Current Ratio is greater than Aditxt, Inc. (0.09), less than Palisade Bio, Inc. (3.31), less than Revelation Biosciences, Inc. (1.64), less than Quoin Pharmaceuticals, Ltd. (3.02), less than Zura Bio Limited (10.36), less than Altamira Therapeutics Ltd. (1.38), less than Immix Biopharma, Inc. (3.47), less than Enveric Biosciences, Inc. (5.17), less than First Wave BioPharma, Inc. (5.34), less than Dermata Therapeutics, Inc. (3.44), greater than Panbela Therapeutics, Inc. (0.26), less than ContraFect Corporation (0.53), less than Protara Therapeutics, Inc. (9.85), less than Vaccinex, Inc. (0.77), less than Monopar Therapeutics Inc. (5.41), less than Miromatrix Medical Inc. (3.46), less than Surrozen, Inc. (7.40), less than Avenue Therapeutics, Inc. (2.70), less than Hoth Therapeutics, Inc. (10.16), less than NeuroBo Pharmaceuticals, Inc. (2.41), less than Virax Biolabs Group Limited (25.94),

Build a custom stock screener for Plus Therapeutics, Inc. (PSTV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Plus Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Plus Therapeutics, Inc. (PSTV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Plus Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.